ASH 2021: Meet Valarie Traynham - Personalized Medicine for a Personal Disease
ASH 2021: Meet Valarie Traynham - Personalized Medicine for a Personal Disease  image
ASH 2021: Meet Valarie Traynham - Personalized Medicine for a Personal Disease
Posted Dec 04, 2021

Fostering community and change are essential parts of Valarie Traynham’s DNA.  After her diagnosis she started attending a local support group and soon found herself leading one in Aurora, Illinois, a western Chicago-area suburb.  And she’s a Myeloma Coach.  Oh, and she moderates the Myeloma Crowd’s African American Community Chapter and Facebook page.

All that plus fitting in her own life, living outside of myeloma’s shadow, is an important idea she wants to convey to fellow patients.

“I became a Myeloma Coach after meeting many patients who did not have a peer mentor to ask questions and find relevant information about myeloma,” said Valarie.  “Since I was diagnosed in 2015, I’ve had a transplant and have taken thalidomide, Velcade, Revlimid, and Kyprolis in various combinations with dexamethasone, I feel like I have something important to share.”

When considering ASH, Valarie says she’s “interested in learning more about precision medicine, what research is being done to uncover specific cancer genomes, and what the significance of MGUS is for diagnosed patients.

“My hope is that this research will eventually lead to tailored therapies for all patients.”

The author Greg Brozeit

about the author
Greg Brozeit

Greg Brozeit has been engaged in myeloma patient advocacy since 1998. He began working with the Myeloma Crowd in 2015. Prior to that, he consulted with Dr. Bart Barlogie at the University of Arkansas after working with the International Myeloma Foundation for 15 years, where he inaugurated the public policy advocacy program, patient support group outreach and IMF Europe, organizing more than 100 physician and patient education programs. He earned his BA in political science from Loyola University in New Orleans and lives in northeast Ohio.

More Myeloma News Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Bristol Myers Squibb
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811